UNSPSC 85816107: Introduction of other hormone into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other hormone into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E053VJ

UNSPSC 85816107, Introduction of other hormone into peripheral artery, percutaneous approach (Commodity), does not align with recent state and local procurement activity in the source material. The code nominally describes a specific medical procedure code, yet the recent opportunities posted under this classification cover telehealth services, nursing home operations, cancer screening, medical director oversight, employee wellness platforms, occupational health evaluations, and opioid treatment programs—none of which involve peripheral artery hormone injection. The mismatch indicates either miscoding by the issuing bodies or a systemic classification error in how state and local procurement offices have tagged these opportunities.

The activity that has been recorded under this code spans multiple issuing bodies and geographies: the Inland Empire Health Plan (California) seeking virtual urgent care vendors; DeKalb County, Georgia requesting medical services; the Nevada Health Authority running comprehensive Program of All Inclusive Care for the Elderly (PACE) operations; San Mateo Medical Center (California) soliciting cancer registry and retinal screening device services; Boulder County Sheriff's Office (Colorado) procuring EMT staffing; and county health systems and state agencies across Texas, Florida, Georgia, and other states pursuing diverse clinical and administrative services. With no recent opportunities directly addressing the procedural scope of the code itself, this taxonomy entry shows little relevant recent activity for vendors focused on peripheral artery hormone delivery. Pursuing opportunities tagged under this code requires careful verification that the actual work scope matches your firm's service lines, as the classification appears unreliable as a filtering mechanism.